| Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 |
|---|---|---|---|---|---|---|
Operating activities: | ||||||
Net income | ||||||
16,166 | 12,339 | 7,619 | 7,141 | 2,692 | 4,420 | 2,163 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Provision for loan losses | ||||||
1,410 | 1,594 | 1,618 | 717 | 531 | 1,122 | 946 |
Gain on sales of loans held for sale, net | ||||||
- | - | - | - | 1,650 | 3,009 | 2,761 |
Gain on sales of portfolio loans | ||||||
- | - | - | - | 1,006 | 2,311 | 1,071 |
Loss (gain) on sale and impairment of real estate owned and other repossessed collateral, net | ||||||
-123 | -23 | -255 | 428 | 63 | 746 | - |
Net unrealized gain on equity securities | ||||||
- | - | - | - | -16 | -12 | -4 |
Amortization of subordinated debt issuance costs | ||||||
110 | 110 | 0 | 0 | - | - | - |
Loss (gain) on sale and impairment of real estate owned and other repossessed collateral, net | ||||||
- | - | - | - | - | - | -5 |
Originations of loans held for sale | ||||||
91,975 | 122,924 | 130,010 | 98,383 | 91,366 | 141,870 | 126,130 |
Net proceeds from sales of loans held for sale | ||||||
99,112 | 153,939 | 134,522 | 126,430 | 89,665 | 146,167 | 124,185 |
Gain on sales of residential loans held for sale | ||||||
931 | 1,452 | 1,684 | 1,877 | - | - | - |
Gain on sales of SBA and other loans held for sale | ||||||
3,873 | 5,642 | 4,178 | 2,821 | - | - | - |
Net decrease (increase) in servicing rights | ||||||
-124 | 1,075 | 657 | - | - | - | - |
Gain on sales of portfolio loans, net | ||||||
- | - | - | - | 1,006 | 2,311 | 1,071 |
Amortization of intangible assets | ||||||
433 | 432 | 477 | 589 | 746 | 943 | 1,266 |
Bank-owned life insurance income, net | ||||||
441 | 454 | 449 | 440 | 451 | 718 | 501 |
Depreciation of premises and equipment | ||||||
1,300 | 1,449 | 1,631 | 1,666 | 1,999 | 1,745 | 1,299 |
Deferred income tax (benefit) provision | ||||||
- | - | - | - | - | - | 1,827 |
Stock-based compensation | ||||||
870 | 945 | 613 | 705 | 686 | 563 | 445 |
Net gain on sale of available-for-sale securities | ||||||
- | - | - | - | - | 792 | 1,111 |
Deferred income tax expense | ||||||
498 | -1,025 | 2,122 | -1,185 | -2,672 | -428 | - |
Gain on sale of assets of insurance division | ||||||
- | - | - | - | - | - | 1,566 |
Amortization of available-for-sale debt securities, net | ||||||
-802 | -1,055 | -1,025 | -1,001 | -1,237 | -1,710 | -1,671 |
Changes in other assets and liabilities: | ||||||
Other assets | ||||||
1,331 | 2,206 | 1,659 | -31 | -576 | -3,630 | 1,253 |
Other liabilities | ||||||
5,782 | 6,715 | 1,882 | 556 | 1,443 | 2,834 | 693 |
Net cash provided by operating activities | ||||||
- | - | - | 21,520 | -5,539 | 1,323 | - |
Net cash provided by operating activities | ||||||
19,454 | 33,990 | 5,094 | - | - | - | -6,974 |
Investing activities: | ||||||
Proceeds from sales of available-for-sale securities | ||||||
- | - | - | - | - | 159,579 | 179,045 |
Purchases of available-for-sale debt securities | ||||||
26,174 | 19,526 | 45,160 | 0 | 48,481 | 167,294 | 185,991 |
Proceeds from maturities and principal payments on investment securities, net | ||||||
33,742 | 21,204 | 46,504 | 11,414 | 56,318 | 15,203 | 22,869 |
Loan purchases | ||||||
124,111 | 112,807 | 99,999 | 82,654 | 79,823 | 121,336 | 101,779 |
Proceeds from sales of portfolio loans | ||||||
- | - | - | - | 9,305 | 7,140 | 8,284 |
Loan originations, principal collections, and purchased loan paydowns, net | ||||||
-32,372 | -16,915 | -28,975 | 24,585 | - | - | - |
Loan originations, principal collections, and purchased loan paydowns, net | ||||||
- | - | - | - | 4,372 | - | - |
Loan originations, principal collections, and purchased loan paydowns, net | ||||||
- | - | - | - | - | 42,217 | 50,333 |
Purchases and disposals of premises and equipment, net | ||||||
981 | 695 | 1,190 | 1,244 | 1,086 | 2,897 | 2,565 |
Redemption of Federal Home Loan Bank stock | ||||||
286 | 470 | 1,694 | 0 | - | - | - |
Proceeds from sales of premises and equipment | ||||||
- | - | - | 369 | 11 | - | 163 |
Proceeds from sales of real estate owned and other repossessed collateral | ||||||
1,266 | 759 | 1,537 | 2,563 | 1,674 | 3,925 | 826 |
(Purchase) redemption of regulatory stock, net | ||||||
- | - | - | - | - | - | -287 |
Proceeds from sale of assets of insurance division | ||||||
- | - | - | - | - | - | 9,889 |
Net cash used in investing activities | ||||||
-83,600 | -93,680 | -67,639 | - | - | - | -18,639 |
Financing activities: | ||||||
Proceeds from life insurance benefits | ||||||
- | - | - | - | - | 628 | - |
Redemption of regulatory stock, net | ||||||
- | - | - | - | 1,619 | -248 | - |
Net cash used in investing activities | ||||||
- | - | - | -94,137 | -64,835 | -63,083 | - |
Issuance of subordinated debt, net of debt issuance costs | ||||||
0 | 0 | 14,512 | 0 | - | - | - |
Net increase in deposits | ||||||
65,090 | 89,423 | 125,679 | 100,601 | 90,266 | 63,424 | 22,362 |
Taxes paid for retirement of common stock and other tax-related APIC adjustment | ||||||
- | - | - | 0 | - | - | - |
Net decrease in short-term borrowings | ||||||
0 | 0 | -2,349 | -635 | 2,359 | -584 | -1,306 |
Dividends paid on preferred stock | ||||||
- | - | - | - | - | 113 | 212 |
Dividends paid on common stock | ||||||
355 | 357 | 380 | 402 | 2,922 | 3,750 | 1,262 |
Repurchase of common stock | ||||||
0 | 6,943 | 3,359 | 6,666 | 2,823 | - | - |
Repayment of FHLBB borrowings and wholesale repurchase agreements | ||||||
-5,000 | -10,000 | -10,000 | -12,500 | - | - | - |
Stock offering costs | ||||||
- | - | - | - | - | 59 | - |
Net proceeds from issuance of common stock | ||||||
- | - | - | - | - | - | 52,667 |
Repayment of FHLB borrowings and wholesale repurchase agreements | ||||||
- | - | - | - | -15,000 | -55,000 | - |
Proceeds from FHLB borrowings | ||||||
- | - | - | - | 15,000 | - | - |
Repayment of other borrowings | ||||||
- | - | - | - | - | - | 2,129 |
Redemption of preferred stock and warrants | ||||||
- | - | - | - | - | 4,326 | - |
Repayment of capital lease obligation | ||||||
268 | 255 | 240 | 190 | 181 | 172 | 164 |
Repurchases for tax withholdings on restricted common stock | ||||||
109 | -8 | 11 | - | - | - | - |
Stock options exercised, net | ||||||
-1,093 | -60 | 0 | - | - | - | - |
Net increase in cash and cash equivalents | ||||||
- | - | - | - | 16,325 | -62,340 | - |
Net cash provided by financing activities | ||||||
58,265 | 71,816 | 123,852 | - | - | - | 69,956 |
Net cash provided by financing activities | ||||||
- | - | - | 80,208 | 86,699 | -580 | - |
Net decrease in cash and cash equivalents | ||||||
-5,881 | 12,126 | 61,307 | 7,591 | - | - | - |
Net (decrease) increase in cash and cash equivalents | ||||||
- | - | - | - | - | - | 44,343 |
Income taxes paid, net | ||||||
- | - | - | - | - | 954 | 321 |
Supplemental schedule of noncash investing activities: | ||||||
Interest paid | ||||||
12,171 | 9,502 | 7,773 | - | - | - | - |
Interest paid | ||||||
- | - | - | 7,487 | 7,496 | 8,751 | 9,774 |
Income taxes paid, net | ||||||
5,341 | 7,670 | 2,166 | 5,664 | 3,500 | - | - |
Transfers from loans to real estate owned and other repossessed collateral, net | ||||||
2,769 | 2,959 | 1,781 | 1,764 | 1,531 | 4,209 | 1,019 |
Transfers from real estate owned and other repossessed collateral to loans | ||||||
- | - | - | - | - | - | 44 |